|
Volumn 13, Issue 7, 2010, Pages 424-426
|
Digestive disease week 2010. Turning science into medicine - Part 2
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ABC 294640;
COG 112;
CYTOTOXIC AGENT;
GAMMA INTERFERON;
INTERLEUKIN 17;
MINNELIDE;
MONOCLONAL ANTIBODY;
NI 0101;
PEPTIDOMIMETIC AGENT;
PHOSPHOTRANSFERASE INHIBITOR;
SPHINGOSINE KINASE;
TOLL LIKE RECEPTOR 4;
TRIPTOLIDE;
TUMOR NECROSIS FACTOR ALPHA;
TUMOR NECROSIS FACTOR ALPHA KINOID;
UNCLASSIFIED DRUG;
NEW DRUG;
ANTIBODY RESPONSE;
ANTIINFLAMMATORY ACTIVITY;
ANTINEOPLASTIC ACTIVITY;
CELL VIABILITY;
CLINICAL TRIAL;
COLITIS;
COLITIS ASSOCIATED CANCER;
CONFERENCE PAPER;
CROHN DISEASE;
DRUG DOSE ESCALATION;
DRUG EFFECT;
DRUG SAFETY;
ENTEROBACTERIACEAE INFECTION;
ENZYME INHIBITION;
HUMAN;
INTESTINE POLYP;
LIVER ISCHEMIA;
NEOPLASM;
NITRATIVE STRESS;
NONHUMAN;
PANCREAS CANCER;
REPERFUSION INJURY;
SURVIVAL;
TREATMENT OUTCOME;
TUMOR VOLUME;
ULCERATIVE COLITIS;
UNSPECIFIED SIDE EFFECT;
WEIGHT REDUCTION;
ANIMAL;
CLINICAL TRIAL (TOPIC);
DIGESTIVE SYSTEM DISEASES;
DRUG SCREENING;
IMMUNIZATION;
IMMUNOLOGY;
ANIMALS;
CLINICAL TRIALS AS TOPIC;
DIGESTIVE SYSTEM DISEASES;
DRUG EVALUATION, PRECLINICAL;
DRUGS, INVESTIGATIONAL;
HUMANS;
IMMUNIZATION;
|
EID: 77954102531
PISSN: 13697056
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (9)
|
References (0)
|